1. A Specific CNOT1 Mutation Results in a Novel Syndrome of Pancreatic Agenesis and Holoprosencephaly through Impaired Pancreatic and Neurological Development
- Author
-
De Franco, Elisa, Watson, Rachel A, Weninger, Wolfgang J, Wong, Chi C, Flanagan, Sarah E, Caswell, Richard, Green, Angela, Tudor, Catherine, Lelliott, Christopher J, Geyer, Stefan H, Maurer-Gesek, Barbara, Reissig, Lukas F, Lango Allen, Hana, Caliebe, Almuth, Siebert, Reiner, Holterhus, Paul Martin, Deeb, Asma, Prin, Fabrice, Hilbrands, Robert, Heimberg, Harry, Ellard, Sian, Hattersley, Andrew T, and Barroso, Inês
- Subjects
Male ,Developmental Disabilities ,Sequence Homology ,agenesis ,Infant, Newborn, Diseases ,neonatal ,Mice ,Holoprosencephaly ,Animals ,Humans ,genetics ,pancreas ,Amino Acid Sequence ,development ,Mice, Knockout ,neurological ,diabetes ,Infant, Newborn ,Infant ,Pancreatic Diseases ,Syndrome ,Embryo, Mammalian ,3. Good health ,Pedigree ,Phenotype ,Mutation ,Female ,Nervous System Diseases ,Transcription Factors - Abstract
We report a recurrent CNOT1 de novo missense mutation, GenBank: NM_016284.4; c.1603C>T (p.Arg535Cys), resulting in a syndrome of pancreatic agenesis and abnormal forebrain development in three individuals and a similar phenotype in mice. CNOT1 is a transcriptional repressor that has been suggested as being critical for maintaining embryonic stem cells in a pluripotent state. These findings suggest that CNOT1 plays a critical role in pancreatic and neurological development and describe a novel genetic syndrome of pancreatic agenesis and holoprosencephaly.